SLRN
Price
$5.16
Change
-$0.82 (-13.71%)
Updated
Nov 14 closing price
TRML
Price
$26.88
Change
+$0.62 (+2.36%)
Updated
Nov 14 closing price
Ad is loading...

SLRN vs TRML

Header iconSLRN vs TRML Comparison
Open Charts SLRN vs TRMLBanner chart's image
ACELYRIN
Price$5.16
Change-$0.82 (-13.71%)
Volume$1.2M
CapitalizationN/A
Tourmaline Bio
Price$26.88
Change+$0.62 (+2.36%)
Volume$187.06K
CapitalizationN/A
SLRN vs TRML Comparison Chart
Loading...
SLRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SLRN vs. TRML commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLRN is a Hold and TRML is a StrongSell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (SLRN: $5.16 vs. TRML: $26.88)
Brand notoriety: SLRN and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLRN: 167% vs. TRML: 76%
Market capitalization -- SLRN: $515.01M vs. TRML: $689.27M
SLRN [@Biotechnology] is valued at $515.01M. TRML’s [@Biotechnology] market capitalization is $689.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLRN’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • SLRN’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, both SLRN and TRML are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLRN’s TA Score shows that 3 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • SLRN’s TA Score: 3 bullish, 5 bearish.
  • TRML’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TRML is a better buy in the short-term than SLRN.

Price Growth

SLRN (@Biotechnology) experienced а -13.28% price change this week, while TRML (@Biotechnology) price change was -2.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

SLRN is expected to report earnings on Nov 13, 2024.

TRML is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($689M) has a higher market cap than SLRN($515M). TRML YTD gains are higher at: 2.674 vs. SLRN (-30.831).
SLRNTRMLSLRN / TRML
Capitalization515M689M75%
EBITDAN/AN/A-
Gain YTD-30.8312.674-1,153%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
SLRNTRML
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 8 days ago
0%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
SLRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

SLRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with OABI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then OABI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
-13.71%
OABI - SLRN
40%
Loosely correlated
N/A
CMND - SLRN
38%
Loosely correlated
N/A
TRML - SLRN
36%
Loosely correlated
+2.36%
ACLX - SLRN
36%
Loosely correlated
-5.05%
THAR - SLRN
36%
Loosely correlated
+2.29%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been loosely correlated with SLRN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TRML jumps, then SLRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+2.36%
SLRN - TRML
37%
Loosely correlated
-13.71%
IMNM - TRML
36%
Loosely correlated
-3.88%
BHVN - TRML
34%
Loosely correlated
-0.77%
PYXS - TRML
32%
Poorly correlated
N/A
VYGR - TRML
31%
Poorly correlated
-7.03%
More